7-100613686-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_023948.5(MOSPD3):c.491C>T(p.Thr164Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000279 in 1,613,048 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_023948.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MOSPD3 | NM_023948.5 | c.491C>T | p.Thr164Met | missense_variant | 3/5 | ENST00000393950.7 | NP_076438.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MOSPD3 | ENST00000393950.7 | c.491C>T | p.Thr164Met | missense_variant | 3/5 | 1 | NM_023948.5 | ENSP00000377522.2 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152192Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000361 AC: 9AN: 249496Hom.: 0 AF XY: 0.0000370 AC XY: 5AN XY: 135132
GnomAD4 exome AF: 0.0000178 AC: 26AN: 1460738Hom.: 0 Cov.: 31 AF XY: 0.0000193 AC XY: 14AN XY: 726740
GnomAD4 genome AF: 0.000125 AC: 19AN: 152310Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74484
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 26, 2024 | The c.491C>T (p.T164M) alteration is located in exon 3 (coding exon 3) of the MOSPD3 gene. This alteration results from a C to T substitution at nucleotide position 491, causing the threonine (T) at amino acid position 164 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at